To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4550 | S1pr4-agonist-5c |
Novel potent and selective agonist activity for S1PR4
More description
|
|
| DCC4549 | S18616 Hydrochloride |
Selective and highly potent alpha2-adrenoceptor agonist
More description
|
|
| DCC4548 | S18327 |
Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors
More description
|
|
| DCC4547 | S-18326 |
Potent and selective thrombin inhibitor for the treatment of thromboembolic disorders
More description
|
|
| DCC4546 | s17834 |
Inhibitor of NADPH oxidase, preventing the structural and functional sequelae of diet-induced metabolic heart disease
More description
|
|
| DCC4545 | S15535 |
Potent, orally active, partial 5-HT1A receptor agonist
More description
|
|
| DCC4544 | S14671 |
Potent 5-HT1A receptor agonist, also acting as a 5-HT2A and 5-HT2C receptor antagonist
More description
|
|
| DCC4543 | s14161 |
Novel inhibitor of D-cyclin transactivation via phosphoinositide 3-kinase pathway
More description
|
|
| DCC4542 | S-1360 |
Novel HIV-1 integrase inhibitor
More description
|
|
| DCC4541 | S-1033 |
FP receptor agonist
More description
|
|
| DCC4540 | S07662 |
Inverse agonist of the constitutive androstane receptor (CAR)
More description
|
|
| DCC4539 | S06-1031 |
Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection
More description
|
|
| DCC4538 | S06-1011 |
Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection
More description
|
|
| DCC4537 | S05014 |
Novel highly effective tyrosinase inhibitor with great potential to be utilized in anti-Parkinsonian syndrome
More description
|
|
| DCC4536 | S007-1558 |
The most viable GPVI modulator, acting as a potent antithrombotic agent
More description
|
|
| DCC4535 | S(+)-o-desmethylraclopride Hbr |
Selective D2 dopamine receptor antagonist; Precursor to radiolabeled S-(-)-raclopride
More description
|
|
| DCC4534 | S(-)-8-hydroxy-dpat Hydrobromide [78095-20-2] |
Partial 5-HT1A serotonin receptor agonist
More description
|
|
| DCC4532 | Rxfp3/4-agonist-1 |
The first Small Molecule RXFP3/4 Agonist, Increasing Food Intake in Rats Upon Acute Central Administration
More description
|
|
| DCC4531 | Rx-111 |
Novel small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), exercising broad spectrum anti-inflammatory activity by inhibition of protein binding to the cell surface GAG, heparan sulfate
More description
|
|
| DCC4530 | Rwj-60475 |
Novel CD45 phosphatase inhibitor
More description
|
|
| DCC4529 | rwj-58259 |
Selective antagonist of protease activated receptor-1
More description
|
|
| DCC4528 | Rwj-51204 |
Potent and selective of the benzodiazepine site on GABA(A) receptors
More description
|
|
| DCC4527 | Rwj50271 |
Inhibitor of LFA-1/ICAM-1 Mediated Cell Adhesion
More description
|
|
| DCC4526 | Rvd2n-3 Dpa |
Natural potent macrophage uptake enhancer of S. aureus and zymosan A bioparticles
More description
|
|
| DCC4525 | Ruvbl1/2-in-b |
Novel specific RUVBL1/2 ATPase inhibitor, radiosensitizing NSCLC, but not normal lung epithelial cells
More description
|
|
| DCC4524 | rutaecarpine-17 |
Inhibitor of Adipogenesis/Lipogenesis with AMPK Activation and UPR Suppression, Reducing Lipid Accumulation in Adipocytes
More description
|
|
| DCC4523 | Ru-nt-93 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|
| DCC4522 | Ru-nt-75 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|
| DCC4521 | Ru-nt-70 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|
| DCC4520 | Ru-nt-102 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|